BSE filing, NSE: AGIOPAPER. Summary written from the filing by ALFA Finder's alert engine.
Agio Paper & Industries Ltd: key numbers
- Share price
- ₹3.10
- Market cap
- ₹5.00 Cr
- Revenue (annual)
- ₹0.00 Cr
- Net profit (annual)
- ₹-18.05 Cr
- P/E (TTM)
- -0.3×Sector 43.1×
- Promoter holding
- 63.56%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Agio Paper & Industries Ltd
All →Agio Paper & Industries Other Announcement
Agio Paper & Industries Ltd submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2026.
Agio Paper & Industries Management Change
Agio Paper & Industries Ltd. announced the re-appointment of Mr. Malay Chakrabarty as Executive Director and M/s. Baid Agarwal Singhi & Co. as Statutory Auditor.
Agio Paper & Industries Annual General Meeting
Agio Paper & Industries held its 41st Annual General Meeting on September 30, 2026. The meeting transacted routine business including financial statement adoption and director appointments.
Agio Paper & Industries Annual Report
Agio Paper & Industries Ltd has submitted its Annual Report for the financial year 2025-2026, in compliance with SEBI (LODR) Regulations.
Agio Paper & Industries Annual General Meeting
Agio Paper & Industries Ltd announced the e-voting facility for its upcoming Annual General Meeting, including dates and instructions for shareholders to cast votes electronically.
Agio Paper & Industries Board Meeting Outcome
Agio Paper held a board meeting approving the Annual General Meeting for September 30, 2026, alongside director and auditor re-appointments.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.